Alternative Approaches to Dose–Response Modeling of Toxicological Endpoints for Risk Assessment: Nonmonotonic Dose Responses for Endocrine Disruptors
暂无分享,去创建一个
[1] J. Bucher,et al. Consortium-Based Science: The NIEHS’s Multipronged, Collaborative Approach to Assessing the Health Effects of Bisphenol A , 2012, Environmental health perspectives.
[2] C. L. Sanders,et al. Commentary: Ethical Issues of Current Health-Protection Policies on Low-Dose Ionizing Radiation , 2014, Dose-response : a publication of International Hormesis Society.
[3] A. Ismail,et al. Nuclear hormone receptor degradation and gene transcription: An update , 2005, IUBMB life.
[4] Rosalind,et al. Research needs for the risk assessment of health and environmental effects of endocrine disruptors: a report of the U.S. EPA-sponsored workshop. , 1996, Environmental health perspectives.
[5] M. Fallat,et al. Fertility and Sterility , 1950, Nature.
[6] M. Lohse,et al. Molecular mechanisms of membrane receptor desensitization. , 1993, Biochimica et biophysica acta.
[7] Anna Beronius,et al. Facilitating the use of non‐standard in vivo studies in health risk assessment of chemicals: a proposal to improve evaluation criteria and reporting , 2014, Journal of applied toxicology : JAT.
[8] Laura N. Vandenberg,et al. Peer-reviewed and unbiased research, rather than ‘sound science’, should be used to evaluate endocrine-disrupting chemicals , 2016, Journal of Epidemiology & Community Health.
[9] L. Vandenberg,et al. Non-Monotonic Dose Responses in Studies of Endocrine Disrupting Chemicals: Bisphenol a as a Case Study , 2014, Dose-response : a publication of International Hormesis Society.
[10] Taisen Iguchi,et al. The Impact of Endocrine Disruption: A Consensus Statement on the State of the Science , 2013, Environmental health perspectives.
[11] D. Michaels. Fomenting scientific uncertainty by David Michaels photographs by mindy jones is their product , 2005 .
[12] N. Olea,et al. Negative controls of cell proliferation: human prostate cancer cells and androgens. , 1989, Cancer research.
[13] B. O’Malley,et al. Proteasome-dependent degradation of the human estrogen receptor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[14] Laura N. Vandenberg,et al. Chlorinated persistent organic pollutants, obesity, and type 2 diabetes. , 2014, Endocrine reviews.
[15] Ruili Huang,et al. Predictive endocrine testing in the 21st century using in vitro assays of estrogen receptor signaling responses. , 2014, Environmental science & technology.
[16] R. Melnick,et al. Biochemical origins of the non-monotonic receptor-mediated dose-response. , 2002, Journal of molecular endocrinology.
[17] R. Tyl. Basic Exploratory Research versus Guideline-Compliant Studies Used for Hazard Evaluation and Risk Assessment: Bisphenol A as a Case Study , 2009, Environmental health perspectives.
[18] Chuck Yu,et al. Environmental health perspectives in Central China , 2014 .
[19] Ocspp Us Epa. About the TSCA Chemical Substance Inventory , 2014 .
[20] R. Melnick,et al. Fundamental Flaws of Hormesis for Public Health Decisions , 2005, Environmental health perspectives.
[21] Shuk-Mei Ho,et al. Chapel Hill bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. , 2007, Reproductive toxicology.
[22] K. Korach,et al. Tissue Distribution and Quantitative Analysis of Estrogen Receptor-α (ERα) and Estrogen Receptor-β (ERβ) Messenger Ribonucleic Acid in the Wild-Type and ERα-Knockout Mouse. , 1997, Endocrinology.
[23] Laura N. Vandenberg,et al. Regulatory decisions on endocrine disrupting chemicals should be based on the principles of endocrinology. , 2013, Reproductive toxicology.
[24] H. Kinyamu,et al. Estrogen Receptor-Dependent Proteasomal Degradation of the Glucocorticoid Receptor Is Coupled to an Increase in Mdm2 Protein Expression , 2003, Molecular and Cellular Biology.
[25] L. Stanley,et al. PXR and CAR: Nuclear Receptors which Play a Pivotal Role in Drug Disposition and Chemical Toxicity , 2006, Drug metabolism reviews.
[26] U. Querfeld,et al. Vitamin D deficiency and toxicity in chronic kidney disease: in search of the therapeutic window , 2010, Pediatric Nephrology.
[27] J. Toppari,et al. Executive Summary to EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals. , 2015, Endocrine reviews.
[28] Regulatory Forum Opinion Piece* , 2013, Toxicologic pathology.
[29] O. Olujimi,et al. Endocrine disrupting chemicals (phenol and phthalates) in the South African environment: a need for more monitoring , 2010 .
[30] T J Woodruff,et al. Endocrine-disrupting chemicals and public health protection: a statement of principles from The Endocrine Society. , 2012, Endocrinology.
[31] M. Hanson,et al. Altered regional blood flow in the fetus: the origins of cardiovascular disease? , 2004, Acta paediatrica.
[32] David M. Reif,et al. Endocrine Profiling and Prioritization of Environmental Chemicals Using ToxCast Data , 2010, Environmental health perspectives.
[33] B. Kobilka,et al. Antagonist-dependent and -independent steps in the mechanism of adrenergic receptor internalization. , 1994, The Journal of biological chemistry.
[34] Carlos Sonnenschein,et al. Perinatally Administered Bisphenol A as a Potential Mammary Gland Carcinogen in Rats , 2013, Environmental health perspectives.
[35] David Michaels,et al. Doubt is their product. , 2005, Scientific American.
[36] C. Sonnenschein,et al. Expression of novel genes linked to the androgen-induced, proliferative shutoff in prostate cancer cells , 1997, The Journal of Steroid Biochemistry and Molecular Biology.
[37] Laura N. Vandenberg,et al. Science and policy on endocrine disrupters must not be mixed: a reply to a “common sense” intervention by toxicology journal editors , 2013, Environmental Health.
[38] Amy D. Kyle,et al. Meeting Report: Moving Upstream—Evaluating Adverse Upstream End Points for Improved Risk Assessment and Decision-Making , 2008, Environmental health perspectives.
[39] J. Gustafsson,et al. Expression of estrogen receptor alpha and beta during mouse embryogenesis , 1999, Mechanisms of Development.
[40] C. Sonnenschein,et al. The mouse uterotrophic assay: a reevaluation of its validity in assessing the estrogenicity of bisphenol A. , 2000, Environmental health perspectives.
[41] K. Coser,et al. Importance of dosage standardization for interpreting transcriptomal signature profiles: Evidence from studies of xenoestrogens , 2006, Proceedings of the National Academy of Sciences.
[42] R. Zoeller,et al. Endocrine disruption for endocrinologists (and others). , 2006, Endocrinology.
[43] J. Bloomquist,et al. Selective effects of insecticides on nigrostriatal dopaminergic nerve pathways. , 2002, Neurotoxicology.
[44] D. Barker,et al. The thrifty phenotype hypothesis. , 2001, British medical bulletin.
[45] Ana M Soto,et al. Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. , 2009, Endocrine reviews.
[46] David Michaels,et al. Manufactured Uncertainty , 2006, Annals of the New York Academy of Sciences.
[47] Åke Bergman,et al. State of the Science of Endocrine Disrupting Chemicals - 2012 , 2012 .
[48] Koji Arizono,et al. Why Public Health Agencies Cannot Depend on Good Laboratory Practices as a Criterion for Selecting Data: The Case of Bisphenol A , 2008, Environmental health perspectives.
[49] Laura N. Vandenberg,et al. The mammary gland response to estradiol: Monotonic at the cellular level, non-monotonic at the tissue-level of organization? , 2006, The Journal of Steroid Biochemistry and Molecular Biology.
[50] F. Grün,et al. Endocrine disrupters as obesogens , 2009, Molecular and Cellular Endocrinology.
[51] Julie E. Goodman,et al. A critique of the European Commission Document, “State of the Art Assessment of Endocrine Disrupters” , 2012, Critical reviews in toxicology.
[52] E. Bülbring,et al. The estimation of œstrin and of male hormone in oily solution , 1935, The Journal of physiology.
[53] R. Dorfman,et al. THE NATURE OF THE ESTROGENIC SUBSTANCE IN HUMAN MALE URINE AND BULL TESTIS , 1935 .
[54] Laura N. Vandenberg,et al. Human exposures to bisphenol A: mismatches between data and assumptions , 2013, Reviews on environmental health.
[55] E. Barrett-Connor,et al. Extremes of endogenous testosterone are associated with increased risk of incident coronary events in older women. , 2010, The Journal of clinical endocrinology and metabolism.
[56] L. Ellestad,et al. Sources, concentrations, and exposure effects of environmental gestagens on fish and other aquatic wildlife, with an emphasis on reproduction. , 2014, General and comparative endocrinology.
[57] K A Thayer,et al. Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[58] J. Škarda,et al. Mouse bioassay for in vivo screening of oestrogen and progesterone antagonists. , 2006, Journal of veterinary medicine. A, Physiology, pathology, clinical medicine.
[59] J. Škarda. Sensitivity and specificity of the bioassay of estrogenicity in mammary gland and seminal vesicles of male mice. , 2002, Physiological research.
[60] P. Bossuyt,et al. Blood pressure response to psychological stressors in adults after prenatal exposure to the Dutch famine , 2006, Journal of hypertension.
[61] P. Boffetta,et al. Comments on the opinions published by Bergman et al. (2015) on Critical Comments on the WHO-UNEP State of the Science of Endocrine Disrupting Chemicals (Lamb et al., 2014). , 2015, Regulatory toxicology and pharmacology : RTP.
[62] Kellyn S. Betts,et al. Tox21 to Date: Steps toward Modernizing Human Hazard Characterization , 2013, Environmental health perspectives.
[63] R. G. York,et al. Male reproductive system parameters in a two-generation reproduction study of ammonium perfluorooctanoate in rats and human relevance. , 2010, Toxicology.
[64] M. Beck,et al. An oral developmental neurotoxicity study of decabromodiphenyl ether (DecaBDE) in rats. , 2011, Birth defects research. Part B, Developmental and reproductive toxicology.
[65] Patience Browne,et al. Screening Chemicals for Estrogen Receptor Bioactivity Using a Computational Model. , 2015, Environmental science & technology.
[66] Clive Osmond,et al. Early onset of coronary artery disease after prenatal exposure to the Dutch famine. , 2006, The American journal of clinical nutrition.
[67] Laura N. Vandenberg,et al. Non-monotonic dose responses in EDSP Tier 1 guideline assays , 2014 .
[68] Naomi Oreskes,et al. Viewpoint: Why Disclosure Matters. , 2015, Environmental science & technology.
[69] Laura N. Vandenberg,et al. Using systematic reviews for hazard and risk assessment of endocrine disrupting chemicals , 2015, Reviews in Endocrine and Metabolic Disorders.
[70] Sharon Munn,et al. Low dose effects and non-monotonic dose responses for endocrine active chemicals: science to practice workshop: workshop summary. , 2013, Chemosphere.
[71] P. Ricci,et al. Endocrine disruptors , 1996 .
[72] W. Xie,et al. Orphan nuclear receptor-mediated xenobiotic regulation in drug metabolism. , 2004, Drug discovery today.
[73] R. Slama,et al. Science-based regulation of endocrine disrupting chemicals in Europe: which approach? , 2016, The lancet. Diabetes & endocrinology.
[74] Laura N Vandenberg,et al. Assessing dose–response relationships for endocrine disrupting chemicals (EDCs): a focus on non-monotonicity , 2015, Environmental Health.
[75] A. Gore. Editorial: an international Riposte to Naysayers of endocrine-disrupting chemicals. , 2013, Endocrinology.
[76] Kenny S. Crump,et al. Calculation of Benchmark Doses from Continuous Data , 1995 .
[77] David M. Reif,et al. Activity profiles of 309 ToxCast™ chemicals evaluated across 292 biochemical targets. , 2011, Toxicology.
[78] J. Haseman,et al. Summary of the National Toxicology Program's report of the endocrine disruptors low-dose peer review. , 2002, Environmental health perspectives.
[79] Julia A. Taylor,et al. Metabolic disruption in male mice due to fetal exposure to low but not high doses of bisphenol A (BPA): evidence for effects on body weight, food intake, adipocytes, leptin, adiponectin, insulin and glucose regulation. , 2013, Reproductive toxicology.
[80] W. Chang,et al. Estimates of Relative Risks for Cancers in a Population after Prolonged Low-Dose-Rate Radiation Exposure: A Follow-up Assessment from 1983 to 2005 , 2008, Radiation research.
[81] B. Blumberg,et al. On the Utility of ToxCast™ and ToxPi as Methods for Identifying New Obesogens , 2016, Environmental health perspectives.
[82] J. Borzelleca. Paracelsus: herald of modern toxicology. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.
[83] P. Hof,et al. Policy Decisions on Endocrine Disruptors Should Be Based on Science across Disciplines: A Response to Dietrich et al. , 2013, Hormone Research in Paediatrics.
[84] David M. Reif,et al. Update on EPA's ToxCast program: providing high throughput decision support tools for chemical risk management. , 2012, Chemical research in toxicology.
[85] Laura N. Vandenberg,et al. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. , 2012, Endocrine reviews.
[86] C. Brisken,et al. Does Cancer Start in the Womb? Altered Mammary Gland Development and Predisposition to Breast Cancer due to in Utero Exposure to Endocrine Disruptors , 2013, Journal of Mammary Gland Biology and Neoplasia.
[87] P. Bossuyt,et al. Reduced intima media thickness in adults after prenatal exposure to the Dutch famine. , 2007, Atherosclerosis.
[88] Laura N. Vandenberg,et al. Designing Endocrine Disruption Out of the Next Generation of Chemicals. , 2013, Green chemistry : an international journal and green chemistry resource : GC.
[89] Salomon Sand,et al. The Benchmark Dose Method—Review of Available Models, and Recommendations for Application in Health Risk Assessment , 2003, Critical reviews in toxicology.
[90] H. Steven Wiley,et al. Receptor downregulation and desensitization enhance the information processing ability of signalling receptors , 2007, BMC Syst. Biol..
[91] Christopher J Borgert,et al. Potency matters: thresholds govern endocrine activity. , 2013, Regulatory toxicology and pharmacology : RTP.
[92] John Peterson Myers,et al. A Clash of Old and New Scientific Concepts in Toxicity, with Important Implications for Public Health , 2009, Environmental health perspectives.
[93] R. Slama,et al. EU regulation of endocrine disruptors: a missed opportunity. , 2016, The lancet. Diabetes & endocrinology.
[94] J. Gustafsson,et al. Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse. , 1997, Endocrinology.
[95] 哲郎 小川,et al. Developmental Origins of Health and Disease説の責任遺伝子の網羅的検索 , 2011 .
[96] J. Oehlmann,et al. Reproductive stimulation by low doses of xenoestrogens contrasts with the view of hormesis as an adaptive response , 2005, Human & experimental toxicology.
[97] D. Dix,et al. The ToxCast program for prioritizing toxicity testing of environmental chemicals. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[98] A. Gore. Neuroendocrine targets of endocrine disruptors , 2010, Hormones.
[99] K. Hong,et al. Cellular Mechanism of the Nonmonotonic Dose Response of Bisphenol A in Rat Cardiac Myocytes , 2014, Environmental health perspectives.
[100] J. Gustafsson,et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. , 1997, Endocrinology.
[101] Paul Mushak,et al. How prevalent is chemical hormesis in the natural and experimental worlds? , 2013, The Science of the total environment.
[102] Richard A Becker,et al. Evaluation of EPA's Tier 1 Endocrine Screening Battery and recommendations for improving the interpretation of screening results. , 2011, Regulatory toxicology and pharmacology : RTP.
[103] A C Gore,et al. EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals. , 2015, Endocrine reviews.
[104] Adrian V. Lee,et al. Policy decisions on endocrine disruptors should be based on science across disciplines , 2013, European journal of endocrinology.
[105] D. Dietrich,et al. Endocrine disruption: fact or urban legend? , 2013, Toxicology letters.
[106] C. Sonnenschein,et al. Does breast cancer start in the womb? , 2008, Basic & clinical pharmacology & toxicology.
[107] B. Blumberg,et al. Endocrine disrupting chemicals and the developmental programming of adipogenesis and obesity. , 2011, Birth defects research. Part C, Embryo today : reviews.
[108] Ruili Huang,et al. Using in Vitro High Throughput Screening Assays to Identify Potential Endocrine-Disrupting Chemicals , 2012, Environmental health perspectives.
[109] K. Dahlman-Wright,et al. Review Nuclear Receptor Signaling | The Open Access Journal of the Nuclear Receptor Signaling Atlas Estrogen receptor β: an overview and update , 2022 .
[110] Taisen Iguchi,et al. A path forward in the debate over health impacts of endocrine disrupting chemicals , 2014, Environmental Health.
[111] Claude Emond,et al. Non-monotonic dose-response relationships and endocrine disruptors: a qualitative method of assessment , 2015, Environmental Health.
[112] L. Giudice,et al. Female reproductive disorders: the roles of endocrine-disrupting compounds and developmental timing. , 2008, Fertility and sterility.
[113] Edward J Calabrese,et al. Toxicology rewrites its history and rethinks its future: Giving equal focus to both harmful and beneficial effects , 2011, Environmental toxicology and chemistry.
[114] K. Wallen. The Organizational Hypothesis: Reflections on the 50th anniversary of the publication of Phoenix, Goy, Gerall, and Young (1959) , 2009, Hormones and Behavior.
[115] M D Shelby,et al. Assessing environmental chemicals for estrogenicity using a combination of in vitro and in vivo assays. , 1996, Environmental Health Perspectives.
[116] K. Korach,et al. Differential Estrogenic Actions of Endocrine-Disrupting Chemicals Bisphenol A, Bisphenol AF, and Zearalenone through Estrogen Receptor α and β in Vitro , 2012, Environmental Health Perspectives.
[117] Kristina A Thayer,et al. Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity. , 2003, Environmental health perspectives.
[118] Philippe Grandjean,et al. Developmental Origins of Health and Disease: Integrating Environmental Influences. , 2015, Endocrinology.
[119] D J Barker,et al. Is lifespan determined in utero? , 1997, Archives of disease in childhood. Fetal and neonatal edition.
[120] Paul Mushak,et al. Hormesis and Its Place in Nonmonotonic Dose–Response Relationships: Some Scientific Reality Checks , 2007, Environmental health perspectives.
[121] K. Fent,et al. Highly active human pharmaceuticals in aquatic systems: A concept for their identification based on their mode of action. , 2010, Aquatic toxicology.
[122] Laura N. Vandenberg,et al. Perinatal Bisphenol A Exposure Increases Estrogen Sensitivity of the Mammary Gland in Diverse Mouse Strains , 2007, Environmental health perspectives.
[123] L. Giudice,et al. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. , 2009, Endocrine reviews.
[124] Julie E Goodman,et al. Low-dose effects and nonmonotonic dose-responses of endocrine disrupting chemicals: has the case been made? , 2012, Regulatory toxicology and pharmacology : RTP.
[125] Bruce Blumberg,et al. Endocrine disrupting chemicals and disease susceptibility , 2011, The Journal of Steroid Biochemistry and Molecular Biology.
[126] Laura N. Vandenberg,et al. Developmental origins of health and disease: a paradigm for understanding disease cause and prevention , 2015, Current opinion in pediatrics.
[127] Sudha Seshadri,et al. Thyroid function and the risk of Alzheimer disease: the Framingham Study. , 2008, Archives of internal medicine.
[128] R. Neubig,et al. ANG II type 1 receptor downregulation does not require receptor endocytosis or G protein coupling. , 2001, American journal of physiology. Cell physiology.
[129] L. Birnbaum. Environmental Chemicals: Evaluating Low-Dose Effects , 2012, Environmental health perspectives.
[130] L. Giudice,et al. State of the Science of Endocrine Disrupting Chemicals - 2012 , 2012 .
[131] A. Gore,et al. Endocrine-disrupting chemicals , 2022, Current Biology.
[132] Ruili Huang,et al. The Tox21 robotic platform for the assessment of environmental chemicals--from vision to reality. , 2013, Drug discovery today.
[133] W. Welshons,et al. Low-dose bioactivity of xenoestrogens in animals: fetal exposure to low doses of methoxychlor and other xenoestrogens increases adult prostate size in mice , 1999, Toxicology and industrial health.
[134] Julie E Goodman,et al. Critical comments on the WHO-UNEP State of the Science of Endocrine Disrupting Chemicals - 2012. , 2014, Regulatory toxicology and pharmacology : RTP.
[135] Laura N. Vandenberg,et al. Low-dose effects of hormones and endocrine disruptors. , 2014, Vitamins and hormones.
[136] Laura N. Vandenberg,et al. Low dose effects of bisphenol A , 2013 .
[137] D. J. Barker. The origins of the developmental origins theory , 2007, Journal of internal medicine.
[138] W. Welshons,et al. Implications for human health of the extensive bisphenol A literature showing adverse effects at low doses: a response to attempts to mislead the public. , 2005, Toxicology.
[139] J. Barnett,et al. Two-generation reproductive and developmental toxicity assessment of dietary N-acetyl-L-aspartic acid in rats. , 2011, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[140] G. B. Gori,et al. Scientifically unfounded precaution drives European Commission's recommendations on EDC regulation, while defying common sense, well-established science and risk assessment principles. , 2013, Toxicology in vitro : an international journal published in association with BIBRA.
[141] N. Bunnett,et al. Regulatory mechanisms that modulate signalling by G-protein-coupled receptors. , 1997, The Biochemical journal.
[142] Meena Kumari,et al. A nonlinear relationship of generalized and central obesity with diurnal cortisol secretion in the Whitehall II study. , 2010, The Journal of clinical endocrinology and metabolism.
[143] D. Tillitt,et al. Effects of the environmental estrogenic contaminants bisphenol A and 17α-ethinyl estradiol on sexual development and adult behaviors in aquatic wildlife species. , 2015, General and comparative endocrinology.
[144] A. Kortenkamp,et al. Statistical Power Considerations Show the Endocrine Disruptor Low-Dose Issue in a New Light , 2007, Environmental health perspectives.
[145] Nancy G Doerrer,et al. Identification and characterization of adverse effects in 21st century toxicology. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.
[146] J. Gustafsson,et al. Biological functions and clinical implications of oestrogen receptors alfa and beta in epithelial tissues , 2008, Journal of internal medicine.
[147] A. Hanberg,et al. Bridging the gap between academic research and regulatory health risk assessment of Endocrine Disrupting Chemicals. , 2014, Current opinion in pharmacology.
[148] Nancy G. Doerrer,et al. Identification and Characterization of Adverse Effects in 21 st Century Toxicology , 2012 .
[149] D. Levy,et al. Plasma Leptin Levels and Incidence of Heart Failure, Cardiovascular Disease, and Total Mortality in Elderly Individuals , 2008, Diabetes Care.
[150] R. Tyl. In honor of the Teratology Society's 50th anniversary: The role of Teratology Society members in the development and evolution of in vivo developmental toxicity test guidelines. , 2010, Birth defects research. Part C, Embryo today : reviews.
[151] K. Grandien,et al. Printed in U.S.A. Copyright © 1997 by The Endocrine Society Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors � and � , 2022 .
[152] A. Hanberg,et al. Health risk assessment procedures for endocrine disrupting compounds within different regulatory frameworks in the European Union. , 2009, Regulatory toxicology and pharmacology : RTP.
[153] C. Sonnenschein,et al. Androgen-induced proliferative quiescence in prostate cancer cells: the role of AS3 as its mediator. , 2000, Proceedings of the National Academy of Sciences of the United States of America.